EA
GCVRZ

Edge Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Edge Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$0 Hold
70
– – ﹤0.01% 968
2018
Q1 		$0 Hold
70
– – ﹤0.01% 1004
2017
Q4 		$0 Hold
70
– – ﹤0.01% 1011
2017
Q3 		$0 Hold
70
– – ﹤0.01% 1056
2017
Q2 		$0 Hold
70
– – ﹤0.01% 1076
2017
Q1 		$0 Hold
70
– – ﹤0.01% 1042
2016
Q4 		$0 Buy
+70
New +$24 ﹤0.01% 917

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Edge Advisors's GCVRZ Position: Q2 2018 in Review

Edge Advisors held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q2 2018 at 70 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Edge Advisors first reported a position in GCVRZ in Q4 2016 and has held it in 7 quarters since. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2018.

  • Edge Advisors held 70 shares of Sanofi Contingent Value Rights worth $0 as of Q2 2018.
  • Edge Advisors left its Sanofi Contingent Value Rights share count unchanged in Q2 2018.
  • Sanofi Contingent Value Rights made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #968 holding.
  • Edge Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2016 and has held it in 7 quarters since.
  • 106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.